Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01052220 · ClinicalTrials.gov registry record · NA

Improving Blood Pressure Control in End-Stage Renal Disease Through a Supportive-Educative Nursing Intervention

A NA study of Hypertension and Hemodialysis, sponsored by Wayne State University.

Completed
Registry status
NA
Development phase
118
Enrollment target
2
Study locations

NCT01052220 is a NA study of Hypertension and Hemodialysis that has completed, run by Wayne State University. The registered enrollment target is 118 participants, below the 3,507-participant average among 470 other Hypertension trials with a reported enrollment target (97% lower). The trial reports 2 study locations across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01052220, a NA study of Hypertension and Hemodialysis, has completed, sponsored by Wayne State University.

COMPLETED
Registry status
NA
Development phase
118 participants
Enrollment target
2
Study locations

Study Summary

The major purpose of this quantitative study is to determine if a 3 month supportive educative nursing intervention incorporating Blood Pressure (BP) education and BP, salt and fluid monitoring, in addition to goal setting and reinforcement will improve BP control in a chronic end-stage renal disease population.

Interventions

  • BEHAVIORAL BP education and BP self-regulation
  • BEHAVIORAL Supportive Educative Nursing Intervention

Study Locations (2)

Michigan

  • Davita Detroit Kresge Hemodialysis Unit - Detroit
  • William Beaumont Hemodialysis Units - Royal Oak

Trial Details

FieldValue
Enrollment Target 118 participants
Start Date 2009-06
Est. Completion 2010-07
Phase NA

Sponsor

Wayne State University

163 total trials

What the Registry Record Tells You About NCT01052220

The ClinicalTrials.gov registry entry for NCT01052220 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 118 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 3,507-participant average among 470 other Hypertension trials with a reported enrollment target (97% lower). The listed sponsor is Wayne State University, which has 163 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Hypertension appearing as the primary indexed condition, and to 2 interventions - of which BP education and BP self-regulation is the first listed.

NCT01052220 reports 2 study locations spanning 1 distinct geographic area - top geographies include Michigan.

Frequently Asked Questions

What is clinical trial NCT01052220 about?

NCT01052220 is a clinical study titled "Improving Blood Pressure Control in End-Stage Renal Disease Through a Supportive-Educative Nursing Intervention". The major purpose of this quantitative study is to determine if a 3 month supportive educative nursing intervention incorporating Blood Pressure (BP) education and BP, salt and fluid monitoring, in addition to goal setting and reinforcement will improve BP control in a chronic end-stage renal diseas...

What is the current status of trial NCT01052220?

This trial is currently completed. It is a NA study. The enrollment target is 118 participants. The study started on 2009-06. Estimated completion is 2010-07.

What conditions does trial NCT01052220 study?

This clinical trial studies the following conditions: Hypertension, Hemodialysis.

What interventions are being tested in trial NCT01052220?

The interventions under investigation include: BP education and BP self-regulation (BEHAVIORAL), Supportive Educative Nursing Intervention (BEHAVIORAL).

Who is sponsoring clinical trial NCT01052220?

This trial is sponsored by Wayne State University, which has 163 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01052220 being conducted?

This trial has 2 study locations across Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Hypertension

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.